|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.26 EUR | +0.58% |
|
+1.53% | +1.53% |
| 02-25 | Alessandro di Cino Appointed as Cardif Assurance Vie Representative on Carmila Board | |
| 02-25 | Carmila Announces Board Changes | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.04 | 2.33 | 2.85 | 2.76 | 2.86 | |||||
Return on Total Capital | 2.22 | 2.51 | 3.03 | 2.93 | 3.08 | |||||
Return On Equity % | -5.82 | 5.79 | 6.38 | 0.08 | 9.36 | |||||
Return on Common Equity | -5.84 | 5.79 | 6.38 | 0.08 | 9.37 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 63.68 | 68.57 | 76.09 | 74.99 | 74.06 | |||||
SG&A Margin | 14.08 | 15 | 15.39 | 16.09 | 16.5 | |||||
EBITDA Margin % | 48.51 | 53.85 | 63.55 | 61.15 | 59.15 | |||||
EBITA Margin % | 48.6 | 53.76 | 63.52 | 61.12 | 58.92 | |||||
EBIT Margin % | 48.45 | 53.79 | 63.51 | 61.08 | 58.67 | |||||
Income From Continuing Operations Margin % | -45.43 | 43.31 | 47.5 | 0.57 | 59.8 | |||||
Net Income Margin % | -45.54 | 43.27 | 47.43 | 0.58 | 59.74 | |||||
Net Avail. For Common Margin % | -45.54 | 43.27 | 47.43 | 0.58 | 59.74 | |||||
Normalized Net Income Margin | 19.35 | 23.98 | 29.38 | 28.3 | 26.42 | |||||
Levered Free Cash Flow Margin | 15.9 | 14.55 | 33.12 | 25.86 | 32.6 | |||||
Unlevered Free Cash Flow Margin | 24.17 | 23.42 | 39.69 | 36.47 | 45.22 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | |||||
Fixed Assets Turnover | 0.07 | 0.08 | 0.08 | 0.08 | 0.09 | |||||
Receivables Turnover (Average Receivables) | 2.71 | 3.24 | 4.16 | 3.66 | 3.94 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.06 | 1.06 | 2.23 | 1.42 | 1.22 | |||||
Quick Ratio | 1.04 | 1.06 | 2.19 | 1.4 | 1.18 | |||||
Operating Cash Flow to Current Liabilities | 0.32 | 0.68 | 1.34 | 0.38 | 1.05 | |||||
Days Sales Outstanding (Average Receivables) | 135.03 | 112.54 | 87.71 | 99.73 | 92.9 | |||||
Average Days Payable Outstanding | 65.37 | 63.76 | 67.19 | 59.68 | 77.88 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 81.25 | 77.29 | 74.42 | 92.77 | 80.62 | |||||
Total Debt / Total Capital | 44.83 | 43.6 | 42.67 | 48.12 | 44.64 | |||||
LT Debt/Equity | 73.47 | 70.55 | 72.26 | 75.32 | 78.36 | |||||
Long-Term Debt / Total Capital | 40.54 | 39.79 | 41.43 | 39.08 | 43.38 | |||||
Total Liabilities / Total Assets | 49.34 | 46.94 | 46.15 | 51.07 | 49.29 | |||||
EBIT / Interest Expense | 3.66 | 3.79 | 4.43 | 3.11 | 2.55 | |||||
EBITDA / Interest Expense | 3.68 | 3.81 | 4.45 | 3.13 | 2.59 | |||||
(EBITDA - Capex) / Interest Expense | 3.67 | 3.81 | 4.45 | 3.13 | 2.59 | |||||
Total Debt / EBITDA | 12.49 | 10.88 | 8.86 | 10.4 | 8.83 | |||||
Net Debt / EBITDA | 10.99 | 9.89 | 7.65 | 7.47 | 8.33 | |||||
Total Debt / (EBITDA - Capex) | 12.55 | 10.88 | 8.86 | 10.4 | 8.83 | |||||
Net Debt / (EBITDA - Capex) | 11.04 | 9.89 | 7.65 | 7.47 | 8.33 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.8 | 1.74 | 4.14 | 3.44 | 9.83 | |||||
Gross Profit, 1 Yr. Growth % | -20.15 | 9.56 | 15.56 | 1.94 | 8.48 | |||||
EBITDA, 1 Yr. Growth % | -25.55 | 12.04 | 22.28 | -0.73 | 4.27 | |||||
EBITA, 1 Yr. Growth % | -24.94 | 12.9 | 22.98 | -0.44 | 5.95 | |||||
EBIT, 1 Yr. Growth % | -25.16 | 12.94 | 22.95 | -0.52 | 5.51 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -282.91 | -197 | 14.21 | -98.76 | 11.43K | |||||
Net Income, 1 Yr. Growth % | -283.67 | -196.66 | 14.16 | -98.73 | 11.2K | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -279.45 | -193.82 | 14.29 | -98.72 | 11.26K | |||||
Normalized Net Income, 1 Yr. Growth % | -39.05 | 26.11 | 31.93 | -0.38 | 2.55 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -4.19 | 1.08 | -1.13 | -4.55 | 12.92 | |||||
Accounts Receivable, 1 Yr. Growth % | 26.84 | -49.18 | 34.71 | 4.83 | -0.54 | |||||
Total Assets, 1 Yr. Growth % | -1.04 | -1.25 | 2.23 | 3.33 | 0.18 | |||||
Common Equity, 1 Yr. Growth % | -7.84 | 3.44 | 3.76 | -6.11 | 3.83 | |||||
Tangible Book Value, 1 Yr. Growth % | -7.86 | 3.44 | 3.79 | -6.07 | 3.83 | |||||
Cash From Operations, 1 Yr. Growth % | -40.32 | 53.43 | 25.01 | -14.36 | 7.33 | |||||
Capital Expenditures, 1 Yr. Growth % | 413.51 | - | - | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -63.16 | -9.37 | 103.39 | -19.24 | 34.36 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -52.94 | -3.15 | 76.54 | -4.96 | 33.29 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 17 | 2.56 | 4.17 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.51 | -1.07 | 2.93 | 3.79 | 6.59 | |||||
Gross Profit, 2 Yr. CAGR % | -7.12 | -6.47 | 12.52 | 8.53 | 5.16 | |||||
EBITDA, 2 Yr. CAGR % | -10.71 | -8.31 | 17.35 | 10.32 | 2.69 | |||||
EBITA, 2 Yr. CAGR % | -10.23 | -8.08 | 17.86 | 10.64 | 2.66 | |||||
EBIT, 2 Yr. CAGR % | -10.36 | -8.06 | 17.84 | 10.6 | 2.45 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 10.09 | 33.2 | 5.25 | -88.1 | 19.59 | |||||
Net Income, 2 Yr. CAGR % | 10.24 | 33.24 | 5.05 | -87.98 | 19.62 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 8.69 | 29.75 | 3.55 | -87.91 | 20.58 | |||||
Normalized Net Income, 2 Yr. CAGR % | -19.33 | -12.33 | 26.86 | 14.64 | 1.07 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.66 | -1.59 | -0.03 | -2.86 | 3.82 | |||||
Accounts Receivable, 2 Yr. CAGR % | 9.62 | -19.71 | -17.26 | 18.83 | 2.11 | |||||
Total Assets, 2 Yr. CAGR % | -0.4 | -1.14 | 0.48 | 2.78 | 1.74 | |||||
Common Equity, 2 Yr. CAGR % | -5.41 | -2.37 | 3.6 | -1.3 | -1.26 | |||||
Tangible Book Value, 2 Yr. CAGR % | -5.42 | -2.38 | 3.62 | -1.26 | -1.24 | |||||
Cash From Operations, 2 Yr. CAGR % | -16.68 | -4.31 | 38.49 | 3.47 | -4.13 | |||||
Capital Expenditures, 2 Yr. CAGR % | 37.57 | - | - | - | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -21.75 | -41.44 | 46.58 | 28.16 | 5.74 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.92 | -31.89 | 30.76 | 29.53 | 13.76 | |||||
Dividend Per Share, 2 Yr. CAGR % | -18.35 | 0 | 8.17 | 9.54 | 3.36 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.27 | 1.59 | 0.64 | 3.1 | 5.76 | |||||
Gross Profit, 3 Yr. CAGR % | -1.69 | -1.86 | 0.36 | 8.88 | 8.52 | |||||
EBITDA, 3 Yr. CAGR % | -3.18 | -3.44 | 1.1 | 11.08 | 8.94 | |||||
EBITA, 3 Yr. CAGR % | -2.99 | -3.2 | 1.3 | 11.4 | 9.02 | |||||
EBIT, 3 Yr. CAGR % | -3.09 | -3.18 | 1.29 | 11.37 | 8.87 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -14.23 | 5.54 | 26.54 | -76.05 | 17.77 | |||||
Net Income, 3 Yr. CAGR % | -14.12 | 5.51 | 26.55 | -75.91 | 17.77 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -18.62 | 3.49 | 24.38 | -76.06 | 18.44 | |||||
Normalized Net Income, 3 Yr. CAGR % | -9.06 | -6.37 | -0.64 | 17.04 | 10.46 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.22 | -0.76 | -1.44 | -1.56 | 2.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.23 | -15.16 | -4.6 | -10.47 | 11.99 | |||||
Total Assets, 3 Yr. CAGR % | 2.25 | -0.68 | -0.03 | 1.42 | 1.9 | |||||
Common Equity, 3 Yr. CAGR % | -2.65 | -2.55 | -0.37 | 0.26 | 0.38 | |||||
Tangible Book Value, 3 Yr. CAGR % | -2.65 | -2.56 | -0.36 | 0.28 | 0.41 | |||||
Cash From Operations, 3 Yr. CAGR % | -13.97 | 2.12 | 4.61 | 17.99 | 4.74 | |||||
Capital Expenditures, 3 Yr. CAGR % | 49.91 | - | - | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -29.17 | -17.09 | -6.67 | 20.16 | 31.5 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -21.54 | -9.24 | -6.44 | 17.56 | 31.71 | |||||
Dividend Per Share, 3 Yr. CAGR % | -12.64 | -12.64 | 5.37 | 6.27 | 7.72 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 9.97 | 9.4 | 7.86 | 2.46 | 2.98 | |||||
Gross Profit, 5 Yr. CAGR % | 1.74 | 3.19 | 3.76 | 2.17 | 2.25 | |||||
EBITDA, 5 Yr. CAGR % | -0.86 | 1.78 | 4.73 | 1.95 | 1.79 | |||||
EBITA, 5 Yr. CAGR % | -0.65 | 1.82 | 4.8 | 2.13 | 1.84 | |||||
EBIT, 5 Yr. CAGR % | -0.71 | 1.83 | 4.8 | 2.11 | 1.75 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -9.42 | -8.24 | -6.91 | -55.91 | 23.71 | |||||
Net Income, 5 Yr. CAGR % | -9.35 | -8.19 | -6.91 | -55.74 | 23.73 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 5.82 | -14.14 | -10.39 | -56.15 | 22.84 | |||||
Normalized Net Income, 5 Yr. CAGR % | -5.33 | 0.69 | 3.89 | 0.85 | 0.04 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.35 | 3.93 | 1.31 | -1.6 | 0.63 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.61 | -5.12 | -1.18 | -2.92 | -1.97 | |||||
Total Assets, 5 Yr. CAGR % | 6.84 | 4.13 | 1.54 | 0.69 | 0.67 | |||||
Common Equity, 5 Yr. CAGR % | 6.2 | 5.01 | -0.2 | -2.05 | -0.73 | |||||
Tangible Book Value, 5 Yr. CAGR % | 6.22 | 5.02 | -0.19 | -2.04 | -0.71 | |||||
Cash From Operations, 5 Yr. CAGR % | -4.73 | 7.73 | 4.08 | 2.66 | 1.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 31.67 | - | - | - | - | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -10.94 | 4.19 | -4.74 | 1.76 | -1.89 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.65 | 5.86 | -3.42 | 4.64 | 1.17 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 37.97 | -4.85 | -4.36 | 4.56 |
- Stock Market
- Equities
- CARM Stock
- Financials Carmila
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















